Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,292 | -8,092 | -4,899 | -2,425 | -10,649 |
| Depreciation Amortization | 17 | -8 | -12 | -8 | -53 |
| Accounts receivable | 483 | 488 | 504 | -162 | -43 |
| Other Working Capital | 1,195 | 555 | 234 | -951 | 387 |
| Other Operating Activity | 1,412 | 888 | 351 | 568 | 1,256 |
| Operating Cash Flow | $-9,185 | $-6,169 | $-3,822 | $-2,978 | $-9,102 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,103 | -16,799 | -2,799 | -5,299 | -3,919 |
| PPE Investments | -31 | -2 | -2 | -2 | 11 |
| Investing Cash Flow | $-16,134 | $-16,801 | $-2,801 | $-5,301 | $-3,908 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5 | -4 | -3 | -2 | -5 |
| Common Stock Issued | 28,850 | 28,888 | 7,698 | 7,698 | 75 |
| Financing Cash Flow | $28,845 | $28,884 | $7,695 | $7,696 | $70 |
| Beginning Cash Position | 3,883 | 3,883 | 3,883 | 3,883 | 16,823 |
| End Cash Position | 7,409 | 9,797 | 4,955 | 3,300 | 3,883 |
| Net Cash Flow | $3,526 | $5,914 | $1,072 | $-583 | $-12,940 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,185 | -6,169 | -3,822 | -2,978 | -9,102 |
| Capital Expenditure | -47 | -2 | -2 | -2 | -2 |
| Free Cash Flow | -9,232 | -6,171 | -3,824 | -2,980 | -9,104 |